Autologous Stem Cell Transplantation for Multiple Myeloma: Single Centre Experience from North India
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology
Link
http://link.springer.com/article/10.1007/s12288-017-0876-y/fulltext.html
Reference33 articles.
1. Kyle RA, Rajkumar SV (2008) Multiple myeloma. Blood 111(6):2962–2972
2. Kumar L, Verma R, Radhakrishnan VR (2010) Recent advances in the management of multiple myeloma. Nat Med J India 23(4):210–218
3. Selby PJ, McElwain TJ, Nandi AC, Perren TJ, Powles RL, Tillyer CR et al (1987) Multiple myeloma treated with high dose intravenous melphalan. Br J Haematol 66(1):55–62
4. Desikan R, Barlogie B, Sawyer J, Ayers D, Tricot G, Badros A et al (2000) Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. Blood 95(12):4008–4010
5. Attal M, Harousseau J-L, Stoppa A-M, Sotto J-J, Fuzibet J-G, Rossi J-F et al (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335(2):91–97
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature;Indian Journal of Cancer;2023-10
2. Hematopoietic stem cell transplantation Experience : A Retrospective analysis from largest center of India’s largest state;2023-04-11
3. Long-Term Outcomes of Autologous Hematopoietic Stem Cell Transplant (HSCT) for Multiple Myeloma: While New Horizons Emerge, It Is Still Only a Silver Lining for Resource-Constrained Settings;Cureus;2023-03-24
4. Autologous stem cell transplantation for multiple myeloma in the novel agent era: Systematic review of Indian data and implications for resource constrained settings;Journal of Cancer Research and Therapeutics;2023
5. Clinical Outcomes of Autologous Hematopoietic Stem Cell Transplant (HSCT) in Multiple Myeloma Patients: 5-year Experience from a Single Centre in North India;South Asian Journal of Cancer;2022-08-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3